Vijay Nadipelli

Economic Burden of Long-Term Complications of Deep Vein Thrombosis after Total Hip Replacement Surgery in the United States

Joseph A. Caprini, Marc Botteman, Jennifer Stephens et al. · Value in Health · 2003 · 182 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States

Marc Botteman, Joseph A. Caprini, Jennifer Stephens et al. · Clinical Therapeutics · 2002 · 59 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients

Peter K. Schädlich, M. Kentsch, Manfred Weber et al. · PharmacoEconomics · 2006 · 24 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15

Cost-Effectiveness of Enoxaparin as Thromboprophylaxis in Acutely Ill Medical Patients in Spain

Mark Nuijten, Fernando Antoñanzas, J Kósa et al. · Value in Health · 2003 · 17 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +11

Cost-effectiveness of enoxaparin as thromboprophylaxis in acutelly ill medical patients from the Italian NHS perspective.

Mark Nuijten, Patrizia Berto, J Kósa et al. · PubMed · 2002 · 13 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17